INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $146,000 | -17.0% | 108,367 | -3.9% | 0.00% | – |
| Q3 2016 | $176,000 | +19.7% | 112,709 | +2.0% | 0.00% | – |
| Q2 2016 | $147,000 | -94.5% | 110,510 | -78.1% | 0.00% | -100.0% |
| Q1 2016 | $2,660,000 | -42.3% | 504,780 | -14.0% | 0.00% | -40.0% |
| Q4 2015 | $4,608,000 | -12.0% | 586,989 | -5.3% | 0.01% | -16.7% |
| Q3 2015 | $5,236,000 | -21.8% | 619,685 | +1.3% | 0.01% | -14.3% |
| Q2 2015 | $6,697,000 | -27.2% | 611,678 | -7.1% | 0.01% | -22.2% |
| Q1 2015 | $9,200,000 | -15.6% | 658,097 | +1.9% | 0.01% | -18.2% |
| Q4 2014 | $10,904,000 | +73.1% | 645,630 | +37.5% | 0.01% | +83.3% |
| Q3 2014 | $6,300,000 | -3.1% | 469,443 | -8.0% | 0.01% | 0.0% |
| Q2 2014 | $6,504,000 | +6.1% | 510,519 | -1.0% | 0.01% | 0.0% |
| Q1 2014 | $6,132,000 | -15.6% | 515,737 | -2.0% | 0.01% | -14.3% |
| Q4 2013 | $7,267,000 | -64.3% | 526,181 | -55.0% | 0.01% | -65.0% |
| Q3 2013 | $20,360,000 | -2.3% | 1,168,110 | -9.2% | 0.02% | -9.1% |
| Q2 2013 | $20,840,000 | – | 1,287,038 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |